PortfoliosLab logoPortfoliosLab logo
MIST vs. MCD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MIST vs. MCD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Milestone Pharmaceuticals Inc. (MIST) and McDonald's Corporation (MCD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MIST achieves a -35.15% return, which is significantly lower than MCD's -10.53% return.


MIST

1D
0.77%
1M
-7.09%
YTD
-35.15%
6M
-36.71%
1Y
-22.49%
3Y*
-25.36%
5Y*
-26.09%
10Y*

MCD

1D
-3.05%
1M
-3.66%
YTD
-10.53%
6M
-13.53%
1Y
-3.76%
3Y*
-0.00%
5Y*
5.37%
10Y*
11.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MIST vs. MCD - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
MIST
Milestone Pharmaceuticals Inc.
-35.15%-14.41%41.32%-57.83%-39.54%-2.24%-58.15%2.56%
MCD
McDonald's Corporation
-10.53%7.89%0.14%15.06%0.51%27.79%11.30%1.55%

Correlation

The correlation between MIST and MCD is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.06

Correlation (All Time)
Calculated using the full available price history since May 9, 2019

0.09

Fundamentals

Market Cap

MIST:

$170.67M

MCD:

$192.72B

EPS

MIST:

-$0.49

MCD:

$12.13

PS Ratio

MIST:

63.69

MCD:

7.04

Total Revenue (TTM)

MIST:

$1.78M

MCD:

$27.45B

Gross Profit (TTM)

MIST:

$1.75M

MCD:

$12.10B

EBITDA (TTM)

MIST:

-$63.04M

MCD:

$14.46B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MIST vs. MCD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MIST
MIST Risk / Return Rank: 3333
Overall Rank
MIST Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
MIST Sortino Ratio Rank: 3636
Sortino Ratio Rank
MIST Omega Ratio Rank: 3636
Omega Ratio Rank
MIST Calmar Ratio Rank: 3030
Calmar Ratio Rank
MIST Martin Ratio Rank: 3030
Martin Ratio Rank

MCD
MCD Risk / Return Rank: 3131
Overall Rank
MCD Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
MCD Sortino Ratio Rank: 2727
Sortino Ratio Rank
MCD Omega Ratio Rank: 2727
Omega Ratio Rank
MCD Calmar Ratio Rank: 3636
Calmar Ratio Rank
MCD Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MIST vs. MCD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Milestone Pharmaceuticals Inc. (MIST) and McDonald's Corporation (MCD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MISTMCDDifference
Sharpe ratioReturn per unit of total volatility

-0.05

Sortino ratioReturn per unit of downside risk

+0.39

Omega ratioGain probability vs. loss probability

1.03

0.98

+0.05

Calmar ratioReturn relative to maximum drawdown

-0.34

-0.19

-0.15

Martin ratioReturn relative to average drawdown

-0.63

-0.48

-0.15

MIST vs. MCD - Sharpe Ratio Comparison

The current MIST Sharpe Ratio is -0.27, which is comparable to the MCD Sharpe Ratio of -0.22. The chart below compares the historical Sharpe Ratios of MIST and MCD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MIST vs. MCD - Drawdown Comparison

The maximum MIST drawdown since its inception was -97.60%, which is greater than MCD's maximum drawdown of -73.20%. Use the drawdown chart below to compare losses from any high point for MIST and MCD.


Loading charts...

Drawdown Indicators


MISTMCDDifference

Max Drawdown

Largest peak-to-trough decline

-97.60%

-73.20%

-24.40%

Max Drawdown (1Y)

Largest decline over 1 year

-65.76%

-19.82%

-45.94%

Max Drawdown (3Y)

Largest decline over 3 years

-82.31%

-19.82%

-62.49%

Max Drawdown (5Y)

Largest decline over 5 years

-93.13%

-19.82%

-73.31%

Max Drawdown (10Y)

Largest decline over 10 years

-36.90%

Current Drawdown

Current decline from peak

-95.17%

-19.82%

-75.35%

Average Drawdown

Average peak-to-trough decline

-78.34%

-14.89%

-63.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.63%

7.82%

+27.81%

Volatility

MIST vs. MCD - Volatility Comparison

Milestone Pharmaceuticals Inc. (MIST) has a higher volatility of 12.76% compared to McDonald's Corporation (MCD) at 5.97%. This indicates that MIST's price experiences larger fluctuations and is considered to be riskier than MCD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MISTMCDDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.76%

5.97%

+6.79%

Volatility (6M)

Calculated over the trailing 6-month period

54.45%

12.42%

+42.03%

Volatility (1Y)

Calculated over the trailing 1-year period

83.41%

16.91%

+66.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.73%

17.34%

+60.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

105.01%

20.44%

+84.57%

Dividends

MIST vs. MCD - Dividend Comparison

MIST has not paid dividends to shareholders, while MCD's dividend yield for the trailing twelve months is around 2.72%.


PositionTTM20252024202320222021202020192018201720162015
MCD
McDonald's Corporation
2.72%2.35%2.34%2.10%2.15%1.96%2.35%2.39%2.36%2.23%2.97%2.91%
MIST
Milestone Pharmaceuticals Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MIST vs. MCD - Financials Comparison

This section allows you to compare key financial metrics between Milestone Pharmaceuticals Inc. and McDonald's Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
238.00K
6.52B
(MIST) Total Revenue
(MCD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


MIST and MCD have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MIST has higher volatility (12.76%) compared to MCD (5.97%). In terms of maximum drawdown, MIST dropped -97.60% vs MCD's -73.20%.

MCD currently has the higher Sharpe Ratio (-0.22 vs -0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MIST and MCD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer